Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS
Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2 + dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat - ScienceDirect
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist | Science
Cariprazine for schizophrenia and bipolar I disorder | MDedge Psychiatry
Biomedicines | Free Full-Text | Dopamine D3 Receptor Plasticity in Parkinson's Disease and L-DOPA-Induced Dyskinesia
Biomolecules | Free Full-Text | Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Discovery, Optimization, and Characterization of Novel D2 Dopamine Receptor Selective Antagonists | Journal of Medicinal Chemistry
The dopamine D3 receptor, a quarter century later - Sokoloff - 2017 - European Journal of Neuroscience - Wiley Online Library
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment - ScienceDirect
Frontiers | Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents - ScienceDirect
Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT | Journal of Nuclear Medicine
Structures of the human dopamine D3 receptor-Gi complexes - ScienceDirect
Lecture #64: Pharmacology: Parkinson and Alzheimer Flashcards | Quizlet
Dopamine Receptor | Dopamine D1, D2 Receptors
Frontiers | Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia